Milne Jill C. — SEC Form 4 filings
SEC reporting owner CIK 1644246. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-12 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | 5 | — | — | 8 |
| Astria Therapeutics, Inc. (ATXS) | CEO and President, Director | 3 | — | — | 5 |
Form 4 filings — Milne Jill C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,288 @ $9.70 | EDGAR |
| 2026-06-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,262 @ $8.91 | EDGAR |
| 2026-03-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 528 @ $8.75 | EDGAR |
| 2026-01-27 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 2,582 · Grant/award (A): 12,272 @ $0 · Grant/award (A): 26,684 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Astria Therapeutics, Inc. (ATXS) | Disposition to issuer (D): 4,377 · Disposition to issuer (D): 195,000 (derivative) · Disposition to issuer (D): 761,000 (derivative) | EDGAR |
| 2025-03-25 | 4 | Astria Therapeutics, Inc. (ATXS) | Grant/award (A): 761,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Astria Therapeutics, Inc. (ATXS) | Grant/award (A): 534,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1644246 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →